Jul. 22 at 5:06 PM
$HRZN This will be the first quarter showing financials reflecting the merge with Monroe. Aside from income compared to the dividend, there will other indicators to check. Some numbers won't be comparable to reports before the merger, but I'd say that the % (not total number) of non-performing loans will be the key indicator of whether business continues to deteriorate. NAV also. New loan originations is important; they've only announced 2 loans since February. We'll see what the JV with Roth has been up to. The relatively high dividend to stock price indicates that the market doesn't believe that the HRZN is a good investment. We all know that the market can be wrong, but it's still scary to go in big on this. This is my first BDC stock, and I have a lot to learn about this niche.
